Evaluación del uso de la bacteria Pseudomona sp en la degradación de polietileno de baja densidad entre los años 2011 al 2021

Durante los últimos 30 años el polietileno de baja densidad más conocido como bolsas plásticas se han convertido de mucha utilidad en nuestras vidas cotidianas, pero su mala disposición y su lenta degradación lo convierten en un problema a nivel global, ante la problemática presentada, la presente investigación tiene como objetivo evaluar la influencia de la bacteria Pseudomona sp en la degradación de polietileno de baja densidad entre los años 2011 al 2021. Esta investigación es descriptiva propositiva ya que se basa en fuentes de información que tengan relación directa con la biodegradación de polietileno de baja densidad mediante el uso de Pseudomona sp. La población fue conformada por 15 estudios de tesis de pregrado, postgrado, artículos científicos o de revisión, finalmente 10 estudios que se convierte en la muestra cumplieron con los criterios de temporalidad (no mayor a 10 años), idioma (español e inglés) y que sus palabras claves son: biodegradación de polietileno de baja densidad y Pseudomona sp. Como resultados tenemos que el mayor porcentaje de biodegradación es de 50,5 % obtenido por Pseudomona Aeruginosa. Concluyendo que factores como la temperatura, el tiempo de biodegradación y el peso del LDPE influye en el porcentaje de biodegradación

Sistemas para la medición, visualización y registro de la radiación solar

SE DISEÑÓ UN SISTEMA PARA LA MEDICIÓN DE LA RADIACIÓN SOLARLa luz solar es esencial para la vida, una exposición moderada a la radiación ultravioleta contribuye a la síntesis de vitamina D, pero exponerse mucho puede ser dañino para la piel, ojos y el sistema inmunitario. Uno de los mayores problemas al exponerse al sol es el cáncer de piel. En México ocurren alrededor de 1,000 casos anuales; los estados con mayor registro de muertes por cáncer son: Ciudad de México, Estado de México, Veracruz y Jalisco [1]. De acuerdo con la doctora Minerva Gómez, Presidenta de la Fundación Mexicana de Dermatología (FMD), este tipo de cáncer ocupa el segundo lugar en frecuencia en nuestro país: el primero en el caso de los hombres, y el segundo respecto a las mujeres [2]. La exposición directa al sol es una amenaza para todas las personas, de manera particular para los menores de edad, por ello es importante contar con medidas preventivas oportunas. La idea de este proyecto es proporcionar a las personas información en tiempo real de la radiación solar a la que se exponen, esto mediante dispositivos que permitan medir el nivel de radiación ultra violeta (UV) y mostrar visualmente la mediación. La propuesta realiza mediciones con múltiples sensores, y mediante un algoritmo ad-hoc mejora el nivel de precisión, el algoritmo también determina el correcto funcionamiento de sensores, haciendo al sistema más confiable; adicionalmente, se guarda un registro de las mediciones, lo cual podrá ser útil para análisis a largo plazo. Todo es implementado usando dispositivos de bajo costo

Knowledge, attitudes and preventive practices of primary health care professionals towards alcohol use: A national, cross-sectional study.

Introduction Primary care (PC) professionals' knowledge about alcohol use has been identified as one of the barriers PC providers face in their clinic. Both PC professionals’ level of training and attitude are crucial in the clinical practice regarding alcohol use. Objective To evaluate the knowledge, attitude, and preventive practices of Spanish PC physicians and nurses towards alcohol use. Design An observational, descriptive, cross-sectional, multi-center study. Methodology Location: PC centers of the Spanish National Health System (NHS). Participants: PC physicians and nurses selected randomly from health care centers, and by sending an e-mail to semFYC and SEMERGEN members. Healthcare providers completed an online survey on knowledge, attitude, and follow-up recommendations for reducing alcohol intake. A descriptive, bivariate, and multivariate statistical analysis was conducted (p<0.05). Results Participants: 1,760 healthcare providers completed the survey (75.6% [95% CI 73.5–77.6] family physicians; 11.4% [95% CI 9.9–12.9] medical residents; and 12.5% [95% CI 10.9–14.1] nurses), with a mean age of 44.7 (SD 11.24, range: 26–64, 95% CI: 47.2–48.2). Knowledge was higher in family physicians (p<0.001), older professionals (Spearman's r = 0.11, p<0.001), and resident trainers (p<0.001). The PC professional most likely to provide advice for reducing alcohol use was: a nurse (p <0.001), female (p = 0.010), between 46 and 55 years old (p <0.001). Conclusions PC providers’ knowledge and preventive practices regarding alcohol use are scarce, hence specific training strategies to increase their knowledge and improve their attitude and skills with regard to this health problem should be considered a healthcare policy priority.post-print507 K

Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, Mexico

During May 2009–April 2010, we analyzed 692 samples of pandemic (H1N1) 2009 virus from patients in Mexico. We detected the H275Y substitution of the neuraminidase gene in a specimen from an infant with pandemic (H1N1) 2009 who was treated with oseltamivir. This virus was susceptible to zanamivir and resistant to adamantanes and oseltamivir

Análisis de costos del control prenatal y atención obstétrica en mujeres embarazadas con peso normal y obesidad

El sobrepeso y la obesidad han ido en aumento en todo el mundo durante los últimos 30 años, convirtiéndose en un problema de salud pública y de interés para los dirigentes en este sector. La obesidad materna se define por exceso de tejido adiposo, definida por un índice de masa corporal (IMC) mayor o igual a 30 kg/m, es la comorbilidad más frecuente durante del embarazo y se asocia con un aumento del riesgo de morbilidad y mortalidad materna. En países como México más de 50% de la población adulta tiene sobrepeso u obesidad. La prevalencia de obesidad abdominal en México es 74.0%, mayor en mujeres (82.8%) que en hombres (64.5%).Antecedentes: La obesidad es el principal factor de riesgo modificable para el desarrollo de enfermedades crónicas no transmisibles, como diabetes mellitus y enfermedad cardiovascular. En las últimas tres décadas la prevalencia de obesidad ha aumentado en el ámbito mundial. Para el 2008 en México los costos atribuibles a la obesidad fueron de 42,000 millones de pesos, equivalente al 13% del gasto total de salud y al 0.3 del PIB. Sin embargo en México existe poca información en cuanto al costo adicional que se deriva de embarazos en mujeres con obesidad. Objetivo: Determinar y comparar el costo del control prenatal y de atención obstétrica en mujeres embarazadas con peso normal y con obesidad. Métodos: Se estudiaron mujeres embarazadas de Enero a Diciembre de 2012. El rango de edad fue 19-37 anos de edad y con índice de masa corporal pregestacional (IMCPG) normal ˜ ( 30 kg/m2). Se costeo el control prenatal (basado en el número de consultas), la atención obstétrica, la vía de resolución y la hospitalización en pesos mexicanos al momento del estudio. Resultados: Hubo 34 pacientes con IMCPG normal, y 48 pacientes con obesidad. La edad promedio fue de 27 anos. Comparando con el grupo normal, los costos en el grupo obesidad se ˜ incrementaron 57% en la atención obstétrica (media en pesos mexicanos 3029.41 para el grupo normal vs. 4770.83 grupo obesidad p < 0.0001), en la vía de resolución se incrementaron 15%, (6221.41 vs. 7128.56 respectivamente, p < 0.001); en la hospitalización se incrementaron 43%, (1407.56 vs. 2012.50 respectivamente p < 0.0001). El costo total se incrementó 23% (16,992 vs. 20,828.56, p < 0.0001). Conclusión: Los costos en mujeres con obesidad embarazadas son mayores que en las mujeres con peso normal por lo que se sugiere la implementación de un programa dirigido al control de peso pregestacional y gestacional para así disminuir costos adicionales

Expansion of Signal Transduction Pathways in Fungi by Extensive Genome Duplication

International audienceno abstrac

The Chemotherapeutic Drug 5-Fluorouracil Promotes PKR-Mediated Apoptosis in a p53- Independent Manner in Colon and Breast Cancer Cells

The chemotherapeutic drug 5-FU is widely used in the treatment of a range of cancers, but resistance to the drug remains a major clinical problem. Since defects in the mediators of apoptosis may account for chemo-resistance, the identification of new targets involved in 5-FU-induced apoptosis is of main clinical interest. We have identified the ds-RNA-dependent protein kinase (PKR) as a key molecular target of 5-FU involved in apoptosis induction in human colon and breast cancer cell lines. PKR distribution and activation, apoptosis induction and cytotoxic effects were analyzed during 5-FU and 5-FU/IFNα treatment in several colon and breast cancer cell lines with different p53 status. PKR protein was activated by 5-FU treatment in a p53-independent manner, inducing phosphorylation of the protein synthesis translation initiation factor eIF-2α and cell death by apoptosis. Furthermore, PKR interference promoted a decreased response to 5-FU treatment and those cells were not affected by the synergistic antitumor activity of 5-FU/IFNα combination. These results, taken together, provide evidence that PKR is a key molecular target of 5-FU with potential relevance in the clinical use of this drug

Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis

BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London

Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study

Background: Surgical site infection (SSI) is one of the most common infections associated with health care, but its importance as a global health priority is not fully understood. We quantified the burden of SSI after gastrointestinal surgery in countries in all parts of the world. Methods: This international, prospective, multicentre cohort study included consecutive patients undergoing elective or emergency gastrointestinal resection within 2-week time periods at any health-care facility in any country. Countries with participating centres were stratified into high-income, middle-income, and low-income groups according to the UN's Human Development Index (HDI). Data variables from the GlobalSurg 1 study and other studies that have been found to affect the likelihood of SSI were entered into risk adjustment models. The primary outcome measure was the 30-day SSI incidence (defined by US Centers for Disease Control and Prevention criteria for superficial and deep incisional SSI). Relationships with explanatory variables were examined using Bayesian multilevel logistic regression models. This trial is registered with ClinicalTrials.gov, number NCT02662231. Findings: Between Jan 4, 2016, and July 31, 2016, 13 265 records were submitted for analysis. 12 539 patients from 343 hospitals in 66 countries were included. 7339 (58·5%) patient were from high-HDI countries (193 hospitals in 30 countries), 3918 (31·2%) patients were from middle-HDI countries (82 hospitals in 18 countries), and 1282 (10·2%) patients were from low-HDI countries (68 hospitals in 18 countries). In total, 1538 (12·3%) patients had SSI within 30 days of surgery. The incidence of SSI varied between countries with high (691 [9·4%] of 7339 patients), middle (549 [14·0%] of 3918 patients), and low (298 [23·2%] of 1282) HDI (p < 0·001). The highest SSI incidence in each HDI group was after dirty surgery (102 [17·8%] of 574 patients in high-HDI countries; 74 [31·4%] of 236 patients in middle-HDI countries; 72 [39·8%] of 181 patients in low-HDI countries). Following risk factor adjustment, patients in low-HDI countries were at greatest risk of SSI (adjusted odds ratio 1·60, 95% credible interval 1·05–2·37; p=0·030). 132 (21·6%) of 610 patients with an SSI and a microbiology culture result had an infection that was resistant to the prophylactic antibiotic used. Resistant infections were detected in 49 (16·6%) of 295 patients in high-HDI countries, in 37 (19·8%) of 187 patients in middle-HDI countries, and in 46 (35·9%) of 128 patients in low-HDI countries (p < 0·001). Interpretation: Countries with a low HDI carry a disproportionately greater burden of SSI than countries with a middle or high HDI and might have higher rates of antibiotic resistance. In view of WHO recommendations on SSI prevention that highlight the absence of high-quality interventional research, urgent, pragmatic, randomised trials based in LMICs are needed to assess measures aiming to reduce this preventable complication

Production of He-4 and (4) in Pb-Pb collisions at root(NN)-N-S=2.76 TeV at the LHC

Results on the production of He-4 and (4) nuclei in Pb-Pb collisions at root(NN)-N-S = 2.76 TeV in the rapidity range vertical bar y vertical bar <1, using the ALICE detector, are presented in this paper. The rapidity densities corresponding to 0-10% central events are found to be dN/dy4(He) = (0.8 +/- 0.4 (stat) +/- 0.3 (syst)) x 10(-6) and dN/dy4 = (1.1 +/- 0.4 (stat) +/- 0.2 (syst)) x 10(-6), respectively. This is in agreement with the statistical thermal model expectation assuming the same chemical freeze-out temperature (T-chem = 156 MeV) as for light hadrons. The measured ratio of (4)/He-4 is 1.4 +/- 0.8 (stat) +/- 0.5 (syst). (C) 2018 Published by Elsevier B.V.Peer reviewe